Deborah R. Kaye

Also affiliated with Clinical Research Institute, Duke Cancer Institute

Economics, Econometrics and FinanceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Disparities in utilization of oral anticancer agents and related costs in elderly patients with metastatic renal cell carcinoma in the United States.”.

Disparities in utilization of oral anticancer agents and related costs in elderly patients with metastatic renal cell carcinoma in the United States.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.29_suppl.106

N/A

0DataRank · unranked

1 citations

Lisa P. Spees, Jessica Pritchard, Melissa A. Greiner, Charles D. Scales, C.D. Baggett +6 more

Real-World Utilization of Oral Anticancer Agents and Related Costs in Older Adults with Metastatic Renal Cell Carcinoma in the United States

Kidney Cancer(2021)10.3233/kca-210119

N/A

0DataRank · unranked

9 citations

Lisa P. Spees, Jessica Pritchard, Melissa A. Greiner, Charles D. Scales, Christopher D. Baggett +6 more

Provider‐ and patient‐level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma

Cancer Medicine(2021)10.1002/cam4.4201

N/A

0DataRank · unranked

4 citations

Stephanie B. Wheeler, Bradford E. Jackson, Christopher D. Baggett, Lauren E. Wilson, Melissa A. Greiner +9 more

Oral anticancer agent (OAA) adherence and survival in elderly patients with metastatic renal cell carcinoma (mRCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.280

N/A

0DataRank · unranked

1 citations

Lauren E. Wilson, Melissa A. Greiner, Lisa P. Spees, Jessica Pritchard, Tian Zhang +5 more

Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma.

Journal of Clinical Oncology(2021)10.1200/jco.2020.39.28_suppl.87

N/A

0DataRank · unranked

0 citations

Stephanie B. Wheeler, Bradford E. Jackson, Christopher D. Baggett, Lauren E. Wilson, Melissa A. Greiner +9 more

Patient- and provider-level predictors of mortality among patients with metastatic renal cell carcinoma receiving oral anticancer agents.

Journal of Clinical Oncology(2021)10.1200/jco.2020.39.28_suppl.116

N/A

0DataRank · unranked

0 citations

Michaela A. Dinan, Bradford E. Jackson, Christopher D. Baggett, Lauren E. Wilson, Melissa A. Greiner +9 more

Patient- And Provider-Level Predictors of Survival Among Patients With Metastatic Renal Cell Carcinoma Initiating Oral Anticancer Agents

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.04.010

N/A

0DataRank · unranked

4 citations

Michaela A. Dinan, Bradford E. Jackson, Christopher D. Baggett, Lauren E. Wilson, Melissa A. Greiner +9 more

Evaluation of mild cognitive impairment and dementia in patients with metastatic renal cell carcinoma

Journal of Geriatric Oncology(2022)10.1016/j.jgo.2021.12.012

N/A

0DataRank · unranked

3 citations

Lauren E. Wilson, Melissa A. Greiner, Jessica Pritchard, Tian Zhang, Deborah R. Kaye +5 more

Factors associated with the quality of end-of-life care for patients with metastatic renal cell carcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.300

N/A

0DataRank · unranked

0 citations

Lauren E. Wilson, Bradford E. Jackson, Lisa P. Spees, Christopher D. Baggett, Melissa A. Greiner +10 more

Medication Payments by Insurers and Patients for the Treatment of Metastatic Castrate-Resistant Prostate Cancer

JCO Oncology Practice(2023)10.1200/op.22.00645

N/A

0DataRank · unranked

8 citations

Hui‐Jie Lee, Alexander Gordee, Daniel J. George, Peter A. Ubel, Charles D. Scales +2 more

Drug costs: acquisition costs are critical but not the entire story of financial toxicity

British Journal of Urology(2023)10.1111/bju.16092

N/A

0DataRank · unranked

4 citations

Deborah R. Kaye

Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma

UNC Libraries(2023)10.17615/p7ah-hs63

N/A

0DataRank · unranked

0 citations

Charles D. Scales, Michaela A. Dinan, Cary P. Gross, Daniel J. George, T. Zhang +9 more

Real-World Utilization of Oral Anticancer Agents and Related Costs in Older Adults with Metastatic Renal Cell Carcinoma in the United States

UNC Libraries(2023)10.17615/wdxk-b083

N/A

0DataRank · unranked

0 citations

Daniel J. George, T. Zhang, Melissa A. Greiner, Jessica Pritchard, Michaela A. Dinan +6 more

Oral Anticancer Agent (OAA) Adherence and Survival in Elderly Patients With Metastatic Renal Cell Carcinoma (mRCC)

Carolina Digital Repository (University of North Carolina at Chapel Hill)(2023)10.17615/rx12-6w51

N/A

0DataRank · unranked

0 citations

Melissa A. Greiner, Daniel J. George, Charles D. Scales, Cary P. Gross, Lauren E. Wilson +8 more

Physician Perspectives on the Nonclinical Factors That Contribute to Decision-Making for Advanced Prostate Cancer Care: A Qualitative Study

JU Open Plus(2024)10.1097/ju9.0000000000000118

N/A

0DataRank · unranked

7 citations

Karissa Tu, J. Kelly Davis, Ada Campagna, Sharron L. Docherty, Jeremy Kurnot +4 more

Reducing financial toxicity in bladder cancer care

Current Opinion in Urology(2024)10.1097/mou.0000000000001218

N/A

0DataRank · unranked

5 citations

Deborah R. Kaye, Jeremy Kurnot

Systemic Treatments for Advanced Prostate Cancer: Relationship Between Health Insurance Plan and Treatment Costs

The American Journal of Managed Care(2024)10.37765/ajmc.2024.89606

N/A

0DataRank · unranked

0 citations

Hui‐Jie Lee, Alexander Gordee, Daniel J. George, Charles D. Scales, Peter A. Ubel +2 more